中文 | EN | 日本語
Financial Reports Latest Updates Industry Maps Economic Calendar

SH PHARMA (02607) Annual Reports

上海醫藥 ・ Listed on the Main Board of the Hong Kong Stock Exchange, classified under Healthcare - Pharmaceuticals & Biotechnology (Medicine Distribution). This page collects every annual report, interim report and results announcement filed by the company. All PDFs come directly from HKEXnews.

15
annual reports
15
interim reports
61
documents
2026
latest year

Company profile

Website:Official site ↗

Financial history

Revenue & profit
Annual · In bn (CNY)
Revenue 284 bn
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Show table:Income statement
Item20092010201120122013201420152016201720182019202020212022202320242025
Revenue31.2 38.7 54.9 68.1 78.2 92.4 106 121 131 159 187 192 216 232 260 275 284
Pre-tax income2.13 2.28 3.04 3.09 3.23 3.80 4.17 4.64 5.20 5.34 6.26 7.18 8.14 8.81 7.05 8.02 9.82
Balance sheet
Annual · In bn (CNY)
Total assets 233 bn Total liabilities 143 bn
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table:Balance sheet
Item20092010201120122013201420152016201720182019202020212022202320242025
Total assets21.9 30.2 47.7 51.1 56.3 64.3 74.3 82.7 94.3 127 137 149 163 198 212 221 233
Total liabilities11.4 17.3 21.7 23.4 27.3 33.2 40.5 45.9 54.7 80.5 87.6 94.4 104 120 132 137 143
Equity10.4 12.8 26.0 27.7 29.0 31.1 33.8 36.8 39.7 46.4 49.4 54.7 59.1 78.0 80.3 83.7 89.8
Returns & leverage
Annual · %
Debt ratio 61.5%
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table:Returns & leverage
Item20092010201120122013201420152016201720182019202020212022202320242025
Debt ratio52.3%57.5%45.5%45.8%48.5%51.7%54.5%55.5%58.0%63.4%64.0%63.3%63.9%60.6%62.1%62.1%61.5%

The five-year summary covers results and balance sheet only — cash flow is not required, so no cash-flow chart is shown.

Source: five-year financial summary in the annual report (Listing Rules App. 16)

SH PHARMA filings by year

About SH PHARMA annual reports

Where can I download SH PHARMA (02607) annual reports?

Every year in the table above links straight to the PDF on HKEXnews, the Hong Kong Stock Exchange's official filing system. Both English and Chinese editions are available. 15 annual reports are indexed, covering 2011 to 2026.

Do Hong Kong listed companies publish quarterly reports?

No. Main Board issuers are only required to publish an interim report (half-year) and an annual report. Quarterly financial reporting is not mandatory, so Hong Kong filings arrive twice a year rather than four times. This page holds 15 interim reports for SH PHARMA.

What is the difference between an annual report and a results announcement?

A results announcement (final or interim) is the condensed financial summary a company releases shortly after the period ends — usually a few dozen pages. The annual report follows months later and contains the audited financial statements, the directors' report and corporate governance disclosures. Read the announcement for the numbers first, the annual report for the full picture.

Source: HKEXnews, the Hong Kong Stock Exchange. All PDF links point to the original files; nothing is re-hosted here.
Browse all Hong Kong listed companies, or read this page in Chinese.